Oncology Institute Inc (The) logo

TOI

Oncology Institute Inc (The)

$6.74

Earnings Summary

Revenue
$55.16Mn
Net Profits
$19.29Mn
Net Profit Margins
34.96%

Highlights

Revenue:

Oncology Institute Inc (The)’s revenue jumped 13.55% since last year same period to $55.16Mn in the Q1 2022. On a quarterly growth basis, Oncology Institute Inc (The) has generated -72.83% fall in its revenue since last 3-months.

Net Profits:

Oncology Institute Inc (The)’s net profit jumped 2036.35% since last year same period to $19.29Mn in the Q1 2022. On a quarterly growth basis, Oncology Institute Inc (The) has generated 291.72% jump in its net profits since last 3-months.

Net Profit Margins:

Oncology Institute Inc (The)’s net profit margin jumped 1805.33% since last year same period to 34.96% in the Q1 2022. On a quarterly growth basis, Oncology Institute Inc (The) has generated 805.56% jump in its net profit margins since last 3-months.

Key Ratios

Key ratios of the Oncology Institute Inc (The) post its Q1 2022 earnings

Earning Per Share (EPS)
0.25
Return on Assets (ROA)
-0.21
Return on Equity (ROE)
-0.17
Dividend Per Share (DPS)
0

Highlights

Earning Per Share (EPS):

Oncology Institute Inc (The)’s earning per share (EPS) jumped 27.86% since last year same period to 0.25 in the Q1 2022. This indicates that the Oncology Institute Inc (The) has generated 27.86% annual rate of jump in its earning per share (EPS) in the last 4 quarters.

Return on Assets (ROA):

Return on assets (ROA) indicates the profitability of the company in relation to its total assets. This ratio tells the financial health of the company. The higher the ROA, the better the company’s financial health. If any company has a ROA in the range of 5% to 20% - it is generally considered good. ROA above 20% is generally considered excellent. Oncology Institute Inc (The)’s return on assets (ROA) stands at -0.21.

Earning Per Share (EPS):

The Return On Equity ratio indicates a company’s ability to turn equity capital received from shareholders into profits. ROE highlights the efficiency of equity capital in running the business. Generally, a return on equity in double digits is considered good. Oncology Institute Inc (The)’s return on equity (ROE) stands at -0.17.

Dividend Per Share (DPS):

Oncology Institute Inc (The) declared 0 dividend per share during the earnings announcement for Q1 2022.

Company Information

Organisation
Oncology Institute Inc (The)